Managing Officer, Cancer-Africa LLC
Miami/Fort Lauderdale Area
Managing Officer, Cancer-Africa LLC
Miami/Fort Lauderdale Area
Much of the thrust of cancer research since the 70s has come from functional genomics, which is about establishing the molecular basis of cancer. With the celerity of the Human Genome Project, about 30 000 genes have been sequence-identified since 2005. Now more than ever, the cancer research enterprise has taken to Cubism, in as much as the biology of cancer is broken-up, analyzed and then all too often reassembled in abstracted form. A wealth of knowledge has come from functional genomics and that knowledge base is forever expanding. Breakthrough cancer therapies have emerged from this new knowledge and yet to most, these are still but 'pies in the sky'. In other words, these new knowledge areas and life-saving therapies are not readily accessible. In Africa, accessibility to the global cancer effort is further restricted by historical artifacts. My professional experience and goals involve:
(1) Engaging multiple areas of cancer research and medical expertise in a bid to synthesize and distill information
(2) Engaging the public in a bid to enhance ‘publicness’ i.e. available and accessible knowledge, infrastructure and health services
(3) Engaging industry to determine what it can ethically and responsibly provide
Cancer Research; Molecular Oncology; International Technology Transfer and Project Development; International Development - Policy, Strategy and System Transformation using the International Relations Constructivist Framework
(Partnership; 1-10 employees; Think Tanks industry)
March 2003 — Present (6 years 5 months)
(Research industry)
June 2005 — August 2006 (1 year 3 months)
Identified and succesfully modeled a role for the Epstein Barr Virus (EBV) encoded microRNA, BHRF1-3, as a novel immune evasion mechanism in EBV related lymphomas.
(Educational Institution; 5001-10,000 employees; Hospital & Health Care industry)
2001 — 2004 (3 years)
Studied the molecular basis of cancer metastasis (spread), with a focus on NFkappB signaling, cross-coupling between NFkappB and Nuclear Receptors and the integration of classic growth factor activated signaling pathways in the modular control of metastasis. Modeled cancer preventive and therapeutic drug strategies based on these insights.
(Educational Institution; 5001-10,000 employees; Hospital & Health Care industry)
1999 — 2001 (2 years)
(1999 to 2001) Post-doctoral cancer research fellow and clinical sub-intern in Orthopaedics. University of Rochester Medical Center - Department of Orthopaedics, Rochester, New York. Mentor: Randy N. Rosier, M.D., Ph.D., Wehle Professor and Chair of the Department of Orthopaedics.
Executive Course , Global Health Diplomacy , 2008
M.A. , International Administration , 2006 — 2007
40 Project Management contact hours at the U. of M. School of Business
"Live" debate on the "Global Rise in Religious Violence" & UN Security Council Simulations, in collaboration with the U. of M. School of Communications: "The Darfur Crisis" as the Ambassador of the Republic of Ghana and Head of the African Union, (2007) & "The Iran Nuclear Crisis" as the Ambassador of the Republic of Congo (2006)
Special Course on "Russia in the World", August 2006, St Petersburg State University - School of International Relations - St Petersburg, Russia.
Graduation Report: "Constructivism: An International Relations Perspective and a Framework for Enhancing Opportunities in Global Cancer Control"
Cancer Research - Molecular Oncology 1999 — 2004
United States Medical Licensing Exam - parts I & II
MD , Medicine , 1992 — 1999
History; Human/Leadership Development; Music (every genre, but I am a an avowed Sting fan); Sports (soccer, squash, golf)
BioVision, UICC, AORTIC, AACR, ISPO
James P. Wilmot Fellowship Award (2001 - 2004)
Janssen Pharmaceutica Foundation Research Award (2001 - 2002)
Recipient of the 2001 American Association for Cancer Research (AACR) - American Family Life Assurance Company (AFLAC) Young Investigator Award for promising and meritorious cancer research
Recipient of an ICRETT (International Cancer Research and Technology Transfer) award, administered by the International Union for the Fight Against Cancer (UICC-Geneva, Switzerland) with federal funds from the National Cancer Institute (NCI-USA).
Recipient of a BioVision.Nxt Fellowship (Lyon, France, 2003) - Biovision is a platform for constructive exchange in the life sciences regrouping nobel laureates and leaders of industry and civil society
Biographee – Marquis Who’s Who in America (2004 – present)